Markets
Nvidia's CEO Jensen Huang Unveils New  Innovations At CES 2025
Nvidia CEO Jensen Huang presenting in Las Vegas on January 6, 2025 (Artur Widak/Getty Images)

Why Nvidia’s concern over China escalated into full-blown alarm

When the data center boom was full-on booming, it was easier for Nvidia to shrug off curbs on its access to the world’s second-largest economy. As that boom wanes, and restrictions on China get tighter, the loss of this growth opportunity stings more and more.

Luke Kawa
6/2/25 11:42AM

In May 2023, when Nvidia’s blowout earnings report unofficially kicked the AI boom into high gear and sent shares ripping 24% higher, “China” was barely on anyone’s lips.

The world’s second-largest economy came up just once as a topic of discussion on that earnings call — pertaining to some softness in the chip designer’s automotive business.

Fast-forward to last week, when China was mentioned 27 times during the earnings call, more than the previous four quarters combined. 

The Trump administration banned Chinese sales of the H20, a version of Nvidia’s Hopper GPU that had been tailored to comply with restrictions on tech shipments to the world’s second-largest economy, back in April.

Prior to this, over the past year, Nvidia had struck a tone of hopeful optimism regarding China, in large part because of the development of those specialized chips. CEO Jensen Huang rarely spoke on the subject on quarterly earnings calls, with CFO Colette Kress touching on the company’s ability to “continue to comply with export controls while serving our customers” (February 2025) and highlighting the alternatives Nvidia had developed for this market. In August 2023, she even noted that “current regulation is achieving the intended results,” adding that “we do not anticipate that additional export restrictions on our data center GPUs, if adopted, would have an immediate material impact to our financial results.”

However, she included this seemingly prophetic line, whose sentiments have since been echoed by Huang: “Over the long term, restrictions prohibiting the sale of our Data Center GPUs to China, if implemented, will result in a permanent loss of an opportunity for the US industry to compete and lead in one of the world’s largest markets.”

The long term, seemingly, is now, and the tone is one of alarm. Here’s Huang on China from last week’s earnings call:

  • “On export control, China is one of the worlds largest AI markets and a springboard to global success. With half of the worlds AI researchers based there, the platform that wins China is positioned to lead globally.”

  • “Today, however, the $50 billion China market is effectively closed to US industry. The H20 export ban ended our Hopper data center business in China.”

  • “The U.S. has based its policy on the assumption that China cannot make AI chips. That assumption was always questionable, and now its clearly wrong.”

What gives? Well, the export controls bite in a much more material and thorough way. After the Biden administration put export controls on chips to China in October 2023, Kress said on the next earnings call that guidance would have been a little higher, but declined to specify exactly how big the hit was.

Last week, Nvidia spelled it out bluntly: a $4.5 billion impairment charge in light of the H20 export ban, $2.5 billion in forgone revenues for Q1, and $8 billion in lost revenues this quarter.

So, for starters, Nvidia is talking about China more because of the scale of the opportunity. The $8 billion in forgone revenues in the current quarter in light of the H20 export ban are more than the total sales of 384 S&P 500 companies — including semi peers AMD and Applied Materials as well as household names like McDonald’s and Mastercard — as of their most recent quarterly report. It’s more than 19 companies in the S&P 500 generated combined in the most recent quarter!

While Nvidia is reportedly preparing a new chip for sale to China, Huang said the limits are “quite stringent at the moment, and we have nothing to announce today” following earnings.

Secondly, Nvidia is perhaps talking about China more because its golden goose — eye-popping data center spending — is looking less shiny. While still growing and still massive, the three-month annualized rate of change for private construction spending on data centers dipped below 10% in April. 

And that slowdown in data center spending is coinciding with the continued deceleration in the annual change of Nvidia’s estimated 12-month sales.

So, in short: you can only grow so fast for so long.

When the data center boom was full-on booming, it was easier to shrug off curbs on your access to the world’s second-largest economy. As that boom wanes and restrictions on China get tighter, the loss of the growth opportunity available in this market stings more and more.

More Markets

See all Markets
markets
Luke Kawa
9/5/25

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.